For the full financial year 2024–25, economists expect GDP growth of 6.3%, just below the government’s earlier estimate of 6.5%.

Mabwell (688062.SH), an innovation-driven biopharmaceutical company with entire industry chain, announced that Albipagrastim alfa for Injection (trade name: MAILISHENG, R&D code: 8MW0511) developed by ...

In light of China’s December 2024 ban on gallium exports, Quantum’s discoveries represent a timely and strategic opportunity to support North American critical mineral independence. These metals are ...

Costco Wholesale had a great Q3 FY 2025 earnings report, but the stock fell after hours. Find out why I maintain my Buy ...

A global selloff in government bonds due to concerns over high debt and bond sales has not left the euro zone unscathed, but ...

As US debt surges, bond yields spike, and Moody's downgrades its credit rating, analysts explain the possible impact on India ...

Bitcoin consolidates around $106,000 after reaching new all-time high, with analysts expecting renewed upward momentum fueled ...

Bitcoin signals a bullish breakout with price targets ranging from $200K to $250K by 2025. Experts eye institutional adoption ...

Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings ...

As Budget 2025–26 looms, one of the most corrosive threats to macroeconomic stability and investor confidence is fiscal ...

The current account registered a higher surplus, driven by remittances and export growth, while reserves have improved, and the exchange rate remains stable, aligned with the market. Inflation has ...

Nick Sheridan explores recent dynamic changes in global investment trends, with a focus on small cap resilience and prospects ...